GlucoTrack (NASDAQ:GCTK) Stock Rating Lowered by Wall Street Zen

GlucoTrack (NASDAQ:GCTK) was downgraded by research analysts at Wall Street Zen to a “strong sell” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of GlucoTrack in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, GlucoTrack currently has a consensus rating of “Sell”.

GlucoTrack Stock Performance

GlucoTrack stock opened at $0.49 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $3.08 million, a PE ratio of -0.03 and a beta of 0.77. The company has a 50 day moving average price of $0.48 and a 200-day moving average price of $1.36. GlucoTrack has a fifty-two week low of $0.29 and a fifty-two week high of $14.14.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Ikarian Capital LLC bought a new stake in shares of GlucoTrack in the 4th quarter valued at about $177,000. Boothbay Fund Management LLC purchased a new stake in shares of GlucoTrack in the 4th quarter worth approximately $52,000. Finally, Bank of America Corp DE boosted its stake in shares of GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock valued at $25,000 after purchasing an additional 4,085 shares in the last quarter. Hedge funds and other institutional investors own 10.92% of the company’s stock.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.